978 related articles for article (PubMed ID: 17894887)
21. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.
Guled M; Lahti L; Lindholm PM; Salmenkivi K; Bagwan I; Nicholson AG; Knuutila S
Genes Chromosomes Cancer; 2009 Jul; 48(7):615-23. PubMed ID: 19396864
[TBL] [Abstract][Full Text] [Related]
22. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation.
Wang X; Liu P; Zhu H; Xu Y; Ma C; Dai X; Huang L; Liu Y; Zhang L; Qin C
Brain Res Bull; 2009 Oct; 80(4-5):268-73. PubMed ID: 19683563
[TBL] [Abstract][Full Text] [Related]
23. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
[TBL] [Abstract][Full Text] [Related]
24. [Oncogenic and tumour suppressor microRNAs].
Finoux AL; Chartrand P
Med Sci (Paris); 2008 Dec; 24(12):1049-54. PubMed ID: 19116113
[TBL] [Abstract][Full Text] [Related]
25. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
Hu X; Macdonald DM; Huettner PC; Feng Z; El Naqa IM; Schwarz JK; Mutch DG; Grigsby PW; Powell SN; Wang X
Gynecol Oncol; 2009 Sep; 114(3):457-64. PubMed ID: 19501389
[TBL] [Abstract][Full Text] [Related]
26. miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer.
Tatarano S; Chiyomaru T; Kawakami K; Enokida H; Yoshino H; Hidaka H; Yamasaki T; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Int J Oncol; 2011 Jul; 39(1):13-21. PubMed ID: 21519788
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers.
Imam JS; Buddavarapu K; Lee-Chang JS; Ganapathy S; Camosy C; Chen Y; Rao MK
Oncogene; 2010 Sep; 29(35):4971-9. PubMed ID: 20603620
[TBL] [Abstract][Full Text] [Related]
28. Target identification of microRNAs expressed highly in human embryonic stem cells.
Li SS; Yu SL; Kao LP; Tsai ZY; Singh S; Chen BZ; Ho BC; Liu YH; Yang PC
J Cell Biochem; 2009 Apr; 106(6):1020-30. PubMed ID: 19229866
[TBL] [Abstract][Full Text] [Related]
29. Slowing down the Ras lane: miRNAs as tumor suppressors?
Morris JP; McManus MT
Sci STKE; 2005 Aug; 2005(297):pe41. PubMed ID: 16107327
[TBL] [Abstract][Full Text] [Related]
30. Deregulated expression of miR-106a predicts survival in human colon cancer patients.
Díaz R; Silva J; García JM; Lorenzo Y; García V; Peña C; Rodríguez R; Muñoz C; García F; Bonilla F; Domínguez G
Genes Chromosomes Cancer; 2008 Sep; 47(9):794-802. PubMed ID: 18521848
[TBL] [Abstract][Full Text] [Related]
31. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.
Liu M; Wu H; Liu T; Li Y; Wang F; Wan H; Li X; Tang H
Cell Res; 2009 Jul; 19(7):828-37. PubMed ID: 19546886
[TBL] [Abstract][Full Text] [Related]
32. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines.
Gaur A; Jewell DA; Liang Y; Ridzon D; Moore JH; Chen C; Ambros VR; Israel MA
Cancer Res; 2007 Mar; 67(6):2456-68. PubMed ID: 17363563
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA expression signatures in solid malignancies.
Galasso M; Sandhu SK; Volinia S
Cancer J; 2012; 18(3):238-43. PubMed ID: 22647360
[TBL] [Abstract][Full Text] [Related]
34. MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers.
Akao Y; Nakagawa Y; Naoe T
Oncol Rep; 2006 Oct; 16(4):845-50. PubMed ID: 16969504
[TBL] [Abstract][Full Text] [Related]
35. E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis.
Lizé M; Pilarski S; Dobbelstein M
Cell Death Differ; 2010 Mar; 17(3):452-8. PubMed ID: 19960022
[TBL] [Abstract][Full Text] [Related]
36. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes.
Kent OA; Mendell JT
Oncogene; 2006 Oct; 25(46):6188-96. PubMed ID: 17028598
[TBL] [Abstract][Full Text] [Related]
37. Sequence variations of microRNAs in human cancer: alterations in predicted secondary structure do not affect processing.
Diederichs S; Haber DA
Cancer Res; 2006 Jun; 66(12):6097-104. PubMed ID: 16778182
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers.
Luthra R; Singh RR; Luthra MG; Li YX; Hannah C; Romans AM; Barkoh BA; Chen SS; Ensor J; Maru DM; Broaddus RR; Rashid A; Albarracin CT
Oncogene; 2008 Nov; 27(52):6667-78. PubMed ID: 18663355
[TBL] [Abstract][Full Text] [Related]
39. MicroRNAs and future therapeutic applications in cancer.
Casalini P; Iorio MV
J BUON; 2009 Sep; 14 Suppl 1():S17-22. PubMed ID: 19785062
[TBL] [Abstract][Full Text] [Related]
40. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma.
Li Y; Tan W; Neo TW; Aung MO; Wasser S; Lim SG; Tan TM
Cancer Sci; 2009 Jul; 100(7):1234-42. PubMed ID: 19486339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
